• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

NCCN Guidelines Revisions and ASCO 2024 Research Outlook

Opinion
Video

An oncologist specializing in breast cancer treatment reviews the latest guideline recommendations for systemic therapies in HR+/HER2- breast cancer, comparing the available CDK4/6 inhibitors and discussing considerations for optimal treatment sequencing.

Related Videos
5 experts are featured in this series.
5 experts are featured in this series.
Dr Michael Bernstein
Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine
2 experts in this video
2 experts in this video
Gladys Antelo-Allen
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.